Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: http://www.cdc.gov/zika/index.html

Revised diagnostic testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories

Filetype[PDF-973.25 KB]


    • Details Related Documents You May Also Like

    Details:

    • Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.
    • Description:
      Revision of: Updated diagnostic testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories. January 13, 2016.

      Memorandum

      Many countries in the Americas now have local transmission of multiple arboviruses that can cause febrile illness with rash, myalgia, or arthralgia. Therefore, laboratory testing has become even more important to confirm the etiology of these diseases. Zika, chikungunya, and dengue virus infections should all be considered for patients with acute fever, rash, myalgia, or arthralgia who have traveled within the previous 2 weeks to an area with ongoing transmission or are living in an area with ongoing transmission. In accordance with the Updated Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age During Ongoing Zika Virus Transmission — United States, 2016 (http://www.cdc.gov/mmwr/volumes/65/wr/mm6505e2er.htm), this test algorithm now includes a recommendation to offer serologic testing to asymptomatic pregnant women with a history of travel to areas with local transmission of Zika virus or are living in an area with ongoing transmission. Laboratory evidence of recent chikungunya, dengue, or Zika virus infection is generally accomplished by testing serum to detect viral nucleic acid or virus- specific immunoglobulin (Ig) M and neutralizing antibodies. However, serological cross- reactivity may occur between Zika and other flaviviruses (e.g., dengue, yellow fever, St. Louis encephalitis, Japanese encephalitis, West Nile), so emphasis should be placed on molecular testing (RT-PCR) in acute specimens received from individuals with clinically compatible illness. Laboratory testing for Zika, chikungunya, and dengue viruses is currently available at CDC and several state and territory health departments.denvchikvzikv-testing-algorithm.pdf

    • Subject:
    • Document Type:
      Pamphlet (or booklet)
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    Related Documents

    This document has replaced (most recent first):
      Updated diagnostic testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories
      Cite
      Filetype[PDF - 364.95 KB]
      Corporate Authors:
      National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.
      January 13, 2016
      Description:
      MemorandumMany countries in the Americas now have local transmission of multiple arboviruses that can cause febrile illness with rash, myalgia, or art...
      Status:
      superseded
      File Type:
      Filetype[PDF - 364.95 KB]
      File Type:
      Filetype[PDF - 364.95 KB]

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov